247 related articles for article (PubMed ID: 38776011)
41. Liver-first approach of colorectal cancer with synchronous hepatic metastases: A reverse strategy.
Waisberg J; Ivankovics IG
World J Hepatol; 2015 Jun; 7(11):1444-9. PubMed ID: 26085905
[TBL] [Abstract][Full Text] [Related]
42. Treatments for colorectal liver metastases: A new focus on a familiar concept.
Zampino MG; Magni E; Ravenda PS; Cella CA; Bonomo G; Della Vigna P; Galdy S; Spada F; Varano GM; Mauri G; Fazio N; Orsi F
Crit Rev Oncol Hematol; 2016 Dec; 108():154-163. PubMed ID: 27931834
[TBL] [Abstract][Full Text] [Related]
43. Role of surgery in colorectal cancer liver metastases.
Akgül Ö; Çetinkaya E; Ersöz Ş; Tez M
World J Gastroenterol; 2014 May; 20(20):6113-22. PubMed ID: 24876733
[TBL] [Abstract][Full Text] [Related]
44. [Management of synchronous colorectal liver metastases].
Dupré A; Gagnière J; Chen Y; Rivoire M
Bull Cancer; 2013 Apr; 100(4):363-71. PubMed ID: 23559319
[TBL] [Abstract][Full Text] [Related]
45. Conventional transarterial chemoembolization combined with systemic therapy versus systemic therapy alone as second-line treatment for unresectable colorectal liver metastases: randomized clinical trial.
Liu Y; Chang W; Zhou B; Wei Y; Tang W; Liang F; Chen Y; Yan Z; Lv M; Ren L; Xu J
Br J Surg; 2021 Apr; 108(4):373-379. PubMed ID: 33611431
[TBL] [Abstract][Full Text] [Related]
46. Treatment of colorectal liver metastases.
Ismaili N
World J Surg Oncol; 2011 Nov; 9():154. PubMed ID: 22115124
[TBL] [Abstract][Full Text] [Related]
47. Assessing resectability of colorectal liver metastases: How do different subspecialties interpret the same data?
Aubin JM; Bressan AK; Grondin SC; Dixon E; MacLean AR; Gregg S; Tang P; Kaplan GG; Martel G; Ball CG
Can J Surg; 2018 Aug; 61(4):251-256. PubMed ID: 30067183
[TBL] [Abstract][Full Text] [Related]
48. Comparison of the Efficacy of D2 Gastrectomy Plus Liver Radiofrequency Combined With Chemotherapy Versus Chemotherapy Alone in the Treatment of Advanced Gastric Cancer With Unresectable Synchronous Liver Metastases: A Multicenter Randomized Controlled Trial Protocol.
Wang W; Gao R; Yu P; Mo Z; Dong D; Yang X; Li X; Ji G
Front Oncol; 2022; 12():802683. PubMed ID: 35296006
[TBL] [Abstract][Full Text] [Related]
49. Hepatic arterial infusion pump chemotherapy combined with systemic chemotherapy for borderline resectable and unresectable colorectal liver metastases: phase II feasibility study.
Krul MF; Kok NFM; Osmani H; Buisman FE; Groot Koerkamp B; Grunhagen DJ; Verhoef C; Mostert B; Snaebjornsson P; Westerink B; Klompenhouwer EG; Donswijk ML; Ruers TJM; Douma JAJ; van Blijderveen N; Kingham TP; D'Angelica MI; Kemeny NE; Bolhuis K; Buffart TE; Kuhlmann KFD
Br J Surg; 2024 Apr; 111(4):. PubMed ID: 38608150
[TBL] [Abstract][Full Text] [Related]
50. Imaging and treatment of patients with colorectal liver metastases in the Netherlands: a survey.
Bipat S; van Leeuwen MS; Ijzermans JN; Bossuyt PM; Greve JW; Stoker J
Neth J Med; 2006 May; 64(5):147-51. PubMed ID: 16702613
[TBL] [Abstract][Full Text] [Related]
51. [Clinical Application of Microwave Ablation in Potentially Resectable Colorectal Cancer With Simultaneously Multiple Liver Metastases].
Han L; Wu XL; Guo F; Xi YN; Chang XY; Zhang CZ; Zhang JF; Ma PC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Apr; 46(2):161-168. PubMed ID: 38686711
[TBL] [Abstract][Full Text] [Related]
52. Local Treatments in the Unresectable Patient with Colorectal Cancer Metastasis: A Review from the Point of View of the Medical Oncologist.
Torres-Jiménez J; Esteban-Villarrubia J; Ferreiro-Monteagudo R; Carrato A
Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885047
[TBL] [Abstract][Full Text] [Related]
53. The clinical effectiveness and cost-effectiveness of ablative therapies in the management of liver metastases: systematic review and economic evaluation.
Loveman E; Jones J; Clegg AJ; Picot J; Colquitt JL; Mendes D; Breen DJ; Moore E; George S; Poston G; Cunningham D; Ruers T; Primrose J
Health Technol Assess; 2014 Jan; 18(7):vii-viii, 1-283. PubMed ID: 24484609
[TBL] [Abstract][Full Text] [Related]
54. Integrating Systemic Therapies into the Multimodality Treatment of Resectable Colorectal Liver Metastases.
Abdel-Rahman O; Cheung WY
Gastroenterol Res Pract; 2018; 2018():4326082. PubMed ID: 30034465
[TBL] [Abstract][Full Text] [Related]
55. Recent Advance in the Surgical Treatment of Metastatic Colorectal Cancer-An English Version.
Park EJ; Baik SH
J Anus Rectum Colon; 2022; 6(4):213-220. PubMed ID: 36348943
[TBL] [Abstract][Full Text] [Related]
56. The management of colorectal liver metastases.
Maher B; Ryan E; Little M; Boardman P; Stedman B
Clin Radiol; 2017 Aug; 72(8):617-625. PubMed ID: 28651746
[TBL] [Abstract][Full Text] [Related]
57. Multidisciplinary approach of colorectal cancer liver metastases.
Fiorentini G; Sarti D; Aliberti C; Carandina R; Mambrini A; Guadagni S
World J Clin Oncol; 2017 Jun; 8(3):190-202. PubMed ID: 28638789
[TBL] [Abstract][Full Text] [Related]
58. Role of stereotactic body radiotherapy in multidisciplinary management of liver metastases in patients with colorectal cancer.
Sanuki N; Takeda A; Tsurugai Y; Eriguchi T
Jpn J Radiol; 2022 Oct; 40(10):1009-1016. PubMed ID: 35857212
[TBL] [Abstract][Full Text] [Related]
59. Surgery and hepatic artery infusion therapy for intrahepatic cholangiocarcinoma.
Scott A; Wong P; Melstrom LG
Surgery; 2023 Jul; 174(1):113-115. PubMed ID: 36906437
[TBL] [Abstract][Full Text] [Related]
60. Current treatment options for patients with initially unresectable isolated colorectal liver metastases.
Kanat O
World J Clin Oncol; 2016 Feb; 7(1):9-14. PubMed ID: 26862487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
